Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-11

Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial completed evaluating the efficacy and safety of a fixed-dose olmesartan/amlodipine/rosuvastatin combination for patients with both hype…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Olmesartan/Amlodipine/Rosuvastatin combination

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Hypertension, Hyperlipidemias | Phase 3 | Status: COMPLETED